0.5651 USD
+0.03 (+6%)
At close: Feb 6, 2026
0.5789 USD
+0.01 (+2.44%)
After Hours: 2/6/2026, 8:19:37 PM
ChartMill assigns a Buy % Consensus number of 46% to BIOX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 2.04. This target is 261% above the current price.
- BIOX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about BIOX.
- In the last month the buy percentage fell by 30 points. So the trust of analysts is decreasing.
- BIOX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-02 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-14 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-09-10 | Lake Street | Maintains | Buy -> Buy |
| 2025-09-10 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-07-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-07 | Lake Street | Maintains | Buy -> Buy |
| 2025-02-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-11 | Roth MKM | Maintains | Buy -> Buy |
| 2024-09-11 | Lake Street | Maintains | Buy -> Buy |
| 2024-09-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-09-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-02 | Roth MKM | Reiterate | Buy |
| 2024-02-09 | Roth MKM | Maintains | Buy -> Buy |
| 2023-11-01 | Roth MKM | Maintains | Buy -> Buy |
| 2023-09-12 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-09-12 | Lake Street | Maintains | Buy -> Buy |
| 2023-08-16 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-04-06 | Oppenheimer | Initiate | Outperform |
| 2022-09-30 | Canaccord Genuity | Initiate | Buy |
| 2021-10-08 | Roth Capital | Initiate | Buy |
| 2021-03-15 | Lake Street | Initiate | Buy |
BIOCERES CROP SOLUTIONS CORP / BIOX FAQ
What is the average price target for BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
7 analysts have analysed BIOX and the average price target is 2.04 USD. This implies a price increase of 261% is expected in the next year compared to the current price of 0.5651.
How do analysts rate BIOCERES CROP SOLUTIONS CORP (BIOX)?
The consensus rating for BIOCERES CROP SOLUTIONS CORP (BIOX) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.